HIV associated nephropathy epidemiology and demographics: Difference between revisions
m Robot: Changing Category:Diseases to Category:Disease |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{HIV associated nephropathy}} | {{HIV associated nephropathy}} | ||
{{CMG}} | {{CMG}}{{APM}};{{AE}}{{KW}} | ||
==Overview== | ==Overview== | ||
==Epidemiology | ==Epidemiology== | ||
===Prevalence=== | |||
===Incidence=== | |||
==Demographics== | |||
===Age=== | |||
===Gender=== | |||
===Race=== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 12:11, 20 December 2016
|
HIV associated nephropathy Microchapters |
|
Differentiating HIV associated nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV associated nephropathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of HIV associated nephropathy epidemiology and demographics |
|
FDA on HIV associated nephropathy epidemiology and demographics |
|
CDC on HIV associated nephropathy epidemiology and demographics |
|
HIV associated nephropathy epidemiology and demographics in the news |
|
Blogs on HIV associated nephropathy epidemiology and demographics |
|
Risk calculators and risk factors for HIV associated nephropathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]